Summary
Matthew Stetz is an analytical AI leader with eight years of experience building ML-driven customer engagement and operations products across pharma, CROs, and biopharma manufacturing. Currently Associate Director at Bristol Myers Squibb, he designs next-best-action prediction and omnichannel orchestration for oncology, hematology, cardiovascular and immunology teams. Previously he applied ML, active learning, and optimization at GSK to accelerate CMC development and led client-facing data science at Medidata to improve clinical trial feasibility and site identification. Trained as a biophysicist (PhD, University of Pennsylvania), he blends quantitative research rigor with product-focused delivery and data governance expertise. On GitHub he contributes to educational data-science notebooks, emphasizing clarity in explaining core algorithms like gradient descent—a hint at his commitment to making complex methods accessible.
8 years of coding experience
4 years of employment as a software developer
PhD Biophysics, PhD Biophysics at University of Pennsylvania